Coronary heart disease prevention: Nutrients, foods, and dietary patterns

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1493-1514

  Bhupathiraju, Shilpa N ^a   Tucker, Katherine L ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Diet; Dietary patterns; Epidemiology; Heart disease; Nutrients

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAROTENOID; CYANOCOBALAMIN; FOLIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PYRIDOXINE; SATURATED FATTY ACID; TRANS FATTY ACID; VITAMIN D;

ALCOHOL CONSUMPTION; CALORIC INTAKE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FAT INTAKE; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD INTAKE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; THERAPY EFFECT; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

CORONARY DISEASE; DIET; HUMANS; NUTRITIVE VALUE;

EID: 79959299900     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.04.038     Document Type: Review

References (306)

1. Center for Disease Control and Prevention, Heart Disease Facts. Atlanta, GA 2010.
2. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2010.
3. Lloyd-Jones D.M., Larson M.G., Beiser A., Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999, 353:89-92.
4. Keys A., Menotti A., Karvonen M.J., et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986, 124:903-915.
5. Slattery M.L., Randall D.E. Trends in coronary heart disease mortality and food consumption in the United States between 1909 and 1980. Am J Clin Nutr 1988, 47:1060-1067.
6. Frantz I.D., Dawson E.A., Ashman P.L., et al. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis 1989, 9:129-135.
7. Turpeinen O., Karvonen M.J., Pekkarinen M., Miettinen M., Elosuo R., Paavilainen E. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol 1979, 8:99-118.
8. Mortality rates after 10.5years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group. JAMA 1990, 263:1795-1801.
9. Keys A., Anderson J.T., Grande F. Prediction of serum-cholesterol responses of man to changes in fats in the diet. Lancet 1957, 273:959-966.
10. Aravanis C., Corcondilas A., Dontas A.S., Lekos D., Keys A. Coronary heart disease in seven countries. IX. The Greek islands of Crete and Corfu. Circulation 1970, 41:I88-I100.
11. Blackburn H., Taylor H.L., Keys A. Coronary heart disease in seven countries. XVI. The electrocardiogram in prediction of five-year coronary heart disease incidence among men aged forty through fifty-nine. Circulation 1970, 41:I154-I161.
12. Buzina R., Keys A., Mohacek I., Marinkovic M., Hahn A., Blackburn H. Coronary heart disease in seven countries. V. Five-year follow-up in Dalmatia and Slavonia. Circulation 1970, 41:I40-I51.
13. Fidanza F., Puddu V., Imbimbo A.B., Menotti A., Keys A. Coronary heart disease in seven countries. VII. Five-year experience in rural Italy. Circulation 1970, 41:I63-I75.
14. Kimura N., Keys A. Coronary heart disease in seven countries. X. Rural southern Japan. Circulation 1970, 41:I101-I112.
15. Taylor H.L., Blackburn H., Keys A., Parlin R.W., Vasquez C., Puchner T. Coronary heart disease in seven countries. IV. Five-year follow-up of employees of selected U.S. railroad companies. Circulation 1970, 41:I20-I39.
16. Taylor H.L., Menotti A., Puddu V., Monti M., Keys A. Coronary heart disease in seven countries. XI. Five years of follow-up of railroad men in Italy. Circulation 1970, 41:I113-I122.
17. Ma Y., Li Y., Chiriboga D.E., et al. Association between carbohydrate intake and serum lipids. J Am Coll Nutr 2006, 25:155-163.
18. Skeaff C.M., Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 2009, 55:173-201.
19. Howard B.V., Van Horn L., Hsia J., et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295:655-666.
20. Lichtenstein A.H., Appel L.J., Brands M., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
21. Center for Nutrition Policy and Promotion, Dietary Guidelines for Americans. In: US Department of Agriculture, editor, 2010.
22. Kromhout D., Menotti A., Bloemberg B., et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995, 24:308-315.
23. Kato H., Tillotson J., Nichaman M.Z., Rhoads G.G., Hamilton H.B. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Am J Epidemiol 1973, 97:372-385.
24. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010, 91:535-546.
25. Scarborough P., Rayner M., van Dis I., Norum K. Meta-analysis of effect of saturated fat intake on cardiovascular disease: overadjustment obscures true associations. Am J Clin Nutr 2010, 92:458-459. author reply 459.
26. Katan M.B., Brouwer I.A., Clarke R., Geleijnse J.M., Mensink R.P. Saturated fat and heart disease. Am J Clin Nutr 2010, 92:459-460. author reply 460-451.
27. Jakobsen M.U., O'Reilly E.J., Heitmann B.L., et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425-1432.
28. Mozaffarian D., Micha R., Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010, 7:e1000252.
29. Mensink R.P., Katan M.B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12:911-919.
30. Hodson L., Skeaff C.M., Chisholm W.A. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Eur J Clin Nutr 2001, 55:908-915.
31. Hu F.B., Stampfer M.J., Manson J.E., et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997, 337:1491-1499.
32. Garcia-Palmieri M.R., Sorlie P., Tillotson J., Costas R., Cordero E., Rodriguez M. Relationship of dietary intake to subsequent coronary heart disease incidence: the Puerto Rico Heart Health Program. Am J Clin Nutr 1980, 33:1818-1827.
33. Kromhout D., de Lezenne Coulander C. Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men. The Zutphen Study. Am J Epidemiol 1984, 119:733-741.
34. Xu J., Eilat-Adar S., Loria C., et al. Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr 2006, 84:894-902.
35. Puiggros C., Chacon P., Armadans L.I., Clapes J., Planas M. Effects of oleic-rich and omega-3-rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients. Clin Nutr 2002, 21:79-87.
36. Schwab U.S., Sarkkinen E.S., Lichtenstein A.H., et al. The effect of quality and amount of dietary fat on the susceptibility of low density lipoprotein to oxidation in subjects with impaired glucose tolerance. Eur J Clin Nutr 1998, 52:452-458.
37. Mata P., Alonso R., Lopez-Farre A., et al. Effect of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro. Arterioscler Thromb Vasc Biol 1996, 16:1347-1355.
38. Willett W.C. Trans fatty acids and cardiovascular disease-epidemiological data. Atheroscler Suppl 2006, 7:5-8.
39. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Trans fatty acids and cardiovascular disease. N Engl J Med 2006, 354:1601-1613.
40. Sun Q., Ma J., Campos H., et al. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 2007, 115:1858-1865.
41. Block R.C., Harris W.S., Reid K.J., Spertus J.A. Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes?. Am Heart J 2008, 156:1117-1123.
42. Mozaffarian D., Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 2009, 63(Suppl 2):S22-S33.
43. Willett W.C., Stampfer M.J., Manson J.E., et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993, 341:581-585.
44. Pietinen P., Ascherio A., Korhonen P., et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997, 145:876-887.
45. Brouwer I.A., Wanders A.J., Katan M.B. Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans-a quantitative review. PLoS One 2010, 5:e9434.
46. Willett W., Mozaffarian D. Ruminant or industrial sources of trans fatty acids: public health issue or food label skirmish?. Am J Clin Nutr 2008, 87:515-516.
47. Administration UFaD, Trans Fat Now Listed with Saturated Fat and Cholesterol on the Nutrition Facts Label. In: Services UDoHaH, editor, 2010.
48. Leth T., Jensen H.G., Mikkelsen A.A., Bysted A. The effect of the regulation on trans fatty acid content in Danish food. Atheroscler Suppl 2006, 7:53-56.
49. Commission BPH, A regulation to restrict foods containing artificial trans fat in the city of Boston. In: Commission BPH, editor, 2008.
50. The New York City Department of Health and Mental Hygiene, NOTICE OF ADOPTION OF AN AMENDMENT ($81.08) TO ARTICLE 81 OF THE NEW YORK CITY HEALTH CODE. 2006.
51. Bang H.O., Dyerberg J., Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976, 200:69-73.
52. Iso H., Kobayashi M., Ishihara J., et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113:195-202.
53. Sun Q., Ma J., Campos H., et al. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr 2008, 88:216-223.
54. Joensen A.M., Schmidt E.B., Dethlefsen C., et al. Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort study. Br J Nutr 2010, 103:602-607.
55. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
56. Lemaitre R.N., King I.B., Mozaffarian D., Kuller L.H., Tracy R.P., Siscovick D.S. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2003, 77:319-325.
57. Guallar E., Hennekens C.H., Sacks F.M., Willett W.C., Stampfer M.J. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol 1995, 25:387-394.
58. Yzebe D., Lievre M. Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2004, 18:581-592.
59. Bucher H.C., Hengstler P., Schindler C., Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002, 112:298-304.
60. Tavazzi L., Maggioni A.P., Marchioli R., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223-1230.
61. Marik P.E., Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol 2009, 32:365-372.
62. Harris W.S., Miller M., Tighe A.P., Davidson M.H., Schaefer E.J. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197:12-24.
63. Hartweg J., Farmer A.J., Perera R., Holman R.R., Neil H.A. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 2007, 50:1593-1602.
64. Jung U.J., Torrejon C., Tighe A.P., Deckelbaum R.J. n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr 2008, 87:2003S-2009S.
65. Wall R., Ross R.P., Fitzgerald G.F., Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010, 68:280-289.
66. Zatonski W., Campos H., Willett W. Rapid declines in coronary heart disease mortality in Eastern Europe are associated with increased consumption of oils rich in alpha-linolenic acid. Eur J Epidemiol 2008, 23:3-10.
67. Billman G.E., Kang J.X., Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 1999, 99:2452-2457.
68. Ander B.P., Weber A.R., Rampersad P.P., Gilchrist J.S., Pierce G.N., Lukas A. Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic Rabbits. J Nutr 2004, 134:3250-3256.
69. Brouwer I.A., Katan M.B., Zock P.L. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004, 134:919-922.
70. Wendland E., Farmer A., Glasziou P., Neil A. Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 2006, 92:166-169.
71. Albert C.M., Oh K., Whang W., et al. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 2005, 112:3232-3238.
72. Lemaitre R.N., King I.B., Sotoodehnia N., et al. Red blood cell membrane alpha-linolenic acid and the risk of sudden cardiac arrest. Metabolism 2009, 58:534-540.
73. Mozaffarian D. Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med 2005, 11:24-30. quiz 31, 79.
74. Humphrey L.L., Fu R., Rogers K., Freeman M., Helfand M. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 2008, 83:1203-1212.
75. Verhoef P., Stampfer M.J., Buring J.E., et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996, 143:845-859.
76. Voutilainen S., Rissanen T.H., Virtanen J., Lakka T.A., Salonen J.T. Low dietary folate intake is associated with an excess incidence of acute coronary events: the Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001, 103:2674-2680.
77. Rimm E.B., Willett W.C., Hu F.B., et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998, 279:359-364.
78. Shaw S., Jayatilleke E., Herbert V., Colman N. Cleavage of folates during ethanol metabolism. Role of acetaldehyde/xanthine oxidase-generated superoxide. Biochem J 1989, 257:277-280.
79. Cui R., Iso H., Date C., Kikuchi S., Tamakoshi A. Dietary folate and vitamin b6 and B12 intake in relation to mortality from cardiovascular diseases: Japan collaborative cohort study. Stroke 2010, 41:1285-1289.
80. Ishihara J., Iso H., Inoue M., et al. Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J Am Coll Nutr 2008, 27:127-136.
81. Dalmeijer G.W., Olthof M.R., Verhoef P., Bots M.L., van der Schouw Y.T. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur J Clin Nutr 2008, 62:386-394.
82. Giles W.H., Kittner S.J., Croft J.B., Anda R.F., Casper M.L., Ford E.S. Serum folate and risk for coronary heart disease: results from a cohort of US adults. Ann Epidemiol 1998, 8:490-496.
83. Chasan-Taber L., Selhub J., Rosenberg I.H., et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 1996, 15:136-143.
84. Voutilainen S., Virtanen J.K., Rissanen T.H., et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2004, 80:317-323.
85. Folsom A.R., Nieto F.J., McGovern P.G., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998, 98:204-210.
86. Siri P.W., Verhoef P., Kok F.J. Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis. J Am Coll Nutr 1998, 17:435-441.
87. Hung J., Beilby J.P., Knuiman M.W., Divitini M. Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia. BMJ 2003, 326:131.
88. Loria C.M., Ingram D.D., Feldman J.J., Wright J.D., Madans J.H. Serum folate and cardiovascular disease mortality among US men and women. Arch Intern Med 2000, 160:3258-3262.
89. Morrison H.I., Schaubel D., Desmeules M., Wigle D.T. Serum folate and risk of fatal coronary heart disease. JAMA 1996, 275:1893-1896.
90. de Bree A., Verschuren W.M., Blom H.J., Nadeau M., Trijbels F.J., Kromhout D. Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study. Atherosclerosis 2003, 166:369-377.
91. Bazzano L.A., Reynolds K., Holder K.N., He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006, 296:2720-2726.
92. Bleys J., Miller E.R., Pastor-Barriuso R., Appel L.J., Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006, 84:880-887. quiz 954-885.
93. de Bree A., van Mierlo L.A., Draijer R. Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2007, 86:610-617.
94. Albert C.M., Cook N.R., Gaziano J.M., et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008, 299:2027-2036.
95. Heinz J., Kropf S., Domrose U., et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation 2010, 121:1432-1438.
96. Jamison R.L., Hartigan P., Kaufman J.S., et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007, 298:1163-1170.
97. Armitage J.M., Bowman L., Clarke R.J., et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 2010, 303:2486-2494.
98. Ebbing M., Bleie O., Ueland P.M., et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008, 300:795-804.
99. Bonaa K.H., Njolstad I., Ueland P.M., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578-1588.
100. Loland K.H., Bleie O., Blix A.J., et al. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol 2010, 105:1577-1584.
101. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999, 340:1449-1454.
102. Mortensen A., Skibsted L.H., Truscott T.G. The interaction of dietary carotenoids with radical species. Arch Biochem Biophys 2001, 385:13-19.
103. Liu S., Lee I.M., Ajani U., Cole S.R., Buring J.E., Manson J.E. Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: the Physicians' Health Study. Int J Epidemiol 2001, 30:130-135.
104. Osganian S.K., Stampfer M.J., Rimm E., Spiegelman D., Manson J.E., Willett W.C. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr 2003, 77:1390-1399.
105. Sesso H.D., Liu S., Gaziano J.M., Buring J.E. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr 2003, 133:2336-2341.
106. Tavani A., Gallus S., Negri E., Parpinel M., La Vecchia C. Dietary intake of carotenoids and retinol and the risk of acute myocardial infarction in Italy. Free Radic Res 2006, 40:659-664.
107. Kabagambe E.K., Furtado J., Baylin A., Campos H. Some dietary and adipose tissue carotenoids are associated with the risk of nonfatal acute myocardial infarction in Costa Rica. J Nutr 2005, 135:1763-1769.
108. Knekt P., Ritz J., Pereira M.A., et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004, 80:1508-1520.
109. Hak A.E., Stampfer M.J., Campos H., et al. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation 2003, 108:802-807.
110. Sesso H.D., Buring J.E., Norkus E.P., Gaziano J.M. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men. Am J Clin Nutr 2005, 81:990-997.
111. Sesso H.D., Buring J.E., Norkus E.P., Gaziano J.M. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr 2004, 79:47-53.
112. Morris D.L., Kritchevsky S.B., Davis C.E. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA 1994, 272:1439-1441.
113. Dwyer J.H., Paul-Labrador M.J., Fan J., Shircore A.M., Merz C.N., Dwyer K.M. Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study. Arterioscler Thromb Vasc Biol 2004, 24:313-319.
114. Iribarren C., Folsom A.R., Jacobs D.R., Gross M.D., Belcher J.D., Eckfeldt J.H. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities. Arterioscler Thromb Vasc Biol 1997, 17:1171-1177.
115. Kristenson M., Zieden B., Kucinskiene Z., et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ 1997, 314:629-633.
116. Ito Y., Kurata M., Suzuki K., Hamajima N., Hishida H., Aoki K. Cardiovascular disease mortality and serum carotenoid levels: a Japanese population-based follow-up study. J Epidemiol 2006, 16:154-160.
117. Buijsse B., Feskens E.J., Kwape L., Kok F.J., Kromhout D. Both alpha- and beta-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men. J Nutr 2008, 138:344-350.
118. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., Topol E.J. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003, 361:2017-2023.
119. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007, 297:842-857.
120. Rapola J.M., Virtamo J., Ripatti S., et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997, 349:1715-1720.
121. Rapola J.M., Virtamo J., Ripatti S., et al. Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris. Heart 1998, 79:454-458.
122. Cook N.R., Albert C.M., Gaziano J.M., et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007, 167:1610-1618.
123. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915-924.
124. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
125. Negre-Salvayre A., Mabile L., Delchambre J., Salvayre R. Alpha-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cells. Biol Trace Elem Res 1995, 47:81-91.
126. Singh U., Devaraj S., Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005, 25:151-174.
127. Devaraj S., Leonard S., Traber M.G., Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008, 44:1203-1208.
128. Devaraj S., Tang R., Adams-Huet B., et al. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007, 86:1392-1398.
129. Gey K.F., Puska P., Jordan P., Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991, 53:326S-334S.
130. Riemersma R.A., Wood D.A., Macintyre C.C., Elton R.A., Gey K.F., Oliver M.F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991, 337:1-5.
131. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993, 328:1450-1456.
132. Bolton-Smith C., Woodward M., Tunstall-Pedoe H. The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr 1992, 46:85-93.
133. Knekt P., Reunanen A., Jarvinen R., Seppanen R., Heliovaara M., Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994, 139:1180-1189.
134. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996, 334:1156-1162.
135. Meyer F., Bairati I., Dagenais G.R. Lower ischemic heart disease incidence and mortality among vitamin supplement users. Can J Cardiol 1996, 12:930-934.
136. Losonczy K.G., Harris T.B., Havlik R.J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996, 64:190-196.
137. Eidelman R.S., Hollar D., Hebert P.R., Lamas G.A., Hennekens C.H. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004, 164:1552-1556.
138. Shekelle P.G., Morton S.C., Jungvig L.K., et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 2004, 19:380-389.
139. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
140. Blumberg J.B., Frei B. Why clinical trials of vitamin E and cardiovascular diseases may be fatally flawed. Commentary on "The relationship between dose of vitamin E and suppression of oxidative stress in humans". Free Radic Biol Med 2007, 43:1374-1376.
141. Roberts L.J., Oates J.A., Linton M.F., et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 2007, 43:1388-1393.
142. Devaraj S., Jialal I. Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?. Nutr Rev 2005, 63:290-293.
143. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11:298-300.
144. Ye Z., Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008, 15:26-34.
145. Lee D.H., Folsom A.R., Harnack L., Halliwell B., Jacobs D.R. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes?. Am J Clin Nutr 2004, 80:1194-1200.
146. Sesso H.D., Buring J.E., Christen W.G., et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
147. McRae M.P. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med 2008, 7:48-58.
148. Picciano M.F. Who is using dietary supplements and what are they using? 2005, American Dietetic Association's Food & Nutrition Conference & Expo, St. Louis, Missouri.
149. Balluz L.S., Kieszak S.M., Philen R.M., Mulinare J. Vitamin and mineral supplement use in the United States. Results from the third National Health and Nutrition Examination Survey. Arch Fam Med 2000, 9:258-262.
150. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483-492.
151. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
152. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168:1174-1180.
153. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167:1159-1165.
154. Scragg R.K., Camargo C.A., Simpson R.U. Relation of serum 25-hydroxyvitamin D to heart rate and cardiac work (from the National Health and Nutrition Examination Surveys). Am J Cardiol 2010, 105:122-128.
155. Melamed M.L., Muntner P., Michos E.D., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008, 28:1179-1185.
156. Reis J.P., Michos E.D., von Muhlen D., Miller E.R. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008, 88:1469-1477.
157. Parker J., Hashmi O., Dutton D., et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010, 65:225-236.
158. Grandi N.C., Breitling L.P., Vossen C.Y., et al. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 2010, 159:1044-1051.
159. Rajasree S., Rajpal K., Kartha C.C., et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 2001, 17:567-571.
160. Vieth R., Rao D.S. Inaccuracies in relating 25-hydroxyvitamin D to ischemic heart disease. Eur J Epidemiol 2003, 18:461-462.
161. Kim D.H., Sabour S., Sagar U.N., Adams S., Whellan D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102:1540-1544.
162. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006, 65:593-597.
163. Cigolini M., Iagulli M.P., Miconi V., Galiotto M., Lombardi S., Targher G. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006, 29:722-724.
164. Pilz S., Dobnig H., Fischer J.E., et al. Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke 2008, 39:2611-2613.
165. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
166. Kilkkinen A., Knekt P., Aro A., et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009, 170:1032-1039.
167. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009, 57:1595-1603.
168. Fiscella K., Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 2010, 8:11-18.
169. Semba R.D., Houston D.K., Bandinelli S., et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010, 64:203-209.
170. Hsia J., Heiss G., Ren H., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854.
171. Jorde R., Sneve M., Torjesen P., Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1year. J Intern Med 2010, 267:462-472.
172. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469.
173. Lock K., Pomerleau J., Causer L., Altmann D.R., McKee M. The global burden of disease attributable to low consumption of fruit and vegetables: implications for the global strategy on diet. Bull World Health Organ 2005, 83:100-108.
174. Dauchet L., Amouyel P., Hercberg S., Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 2006, 136:2588-2593.
175. He F.J., Nowson C.A., Lucas M., MacGregor G.A. Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens 2007, 21:717-728.
176. Holmberg S., Thelin A., Stiernstrom E.L. Food choices and coronary heart disease: a population based cohort study of rural Swedish men with 12years of follow-up. Int J Environ Res Public Health 2009, 6:2626-2638.
177. Tucker K.L., Hallfrisch J., Qiao N., Muller D., Andres R., Fleg J.L. The combination of high fruit and vegetable and low saturated fat intakes is more protective against mortality in aging men than is either alone: the Baltimore Longitudinal Study of Aging. J Nutr 2005, 135:556-561.
178. Nikolic M., Nikic D., Petrovic B. Fruit and vegetable intake and the risk for developing coronary heart disease. Cent Eur J Public Health 2008, 16:17-20.
179. Panagiotakos D.B., Pitsavos C., Kokkinos P., et al. Consumption of fruits and vegetables in relation to the risk of developing acute coronary syndromes; the CARDIO2000 case-control study. Nutr J 2003, 2:2.
180. Hansen L., Dragsted L.O., Olsen A., et al. Fruit and vegetable intake and risk of acute coronary syndrome. Br J Nutr 2010, 104:248-255.
181. Dauchet L., Ferrieres J., Arveiler D., et al. Frequency of fruit and vegetable consumption and coronary heart disease in France and Northern Ireland: the PRIME study. Br J Nutr 2004, 92:963-972.
182. Dauchet L., Montaye M., Ruidavets J.B., et al. Association between the frequency of fruit and vegetable consumption and cardiovascular disease in male smokers and non-smokers. Eur J Clin Nutr 2010, 64:578-586.
183. Gaziano J.M., Manson J.E., Branch L.G., Colditz G.A., Willett W.C., Buring J.E. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995, 5:255-260.
184. Pietinen P., Rimm E.B., Korhonen P., et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation 1996, 94:2720-2727.
185. Nagura J., Iso H., Watanabe Y., et al. Fruit, vegetable and bean intake and mortality from cardiovascular disease among Japanese men and women: the JACC Study. Br J Nutr 2009, 102:285-292.
186. Genkinger J.M., Platz E.A., Hoffman S.C., Comstock G.W., Helzlsouer K.J. Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol 2004, 160:1223-1233.
187. Rissanen T.H., Voutilainen S., Virtanen J.K., et al. Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. J Nutr 2003, 133:199-204.
188. Fraser G.E., Sabate J., Beeson W.L., Strahan T.M. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med 1992, 152:1416-1424.
189. Bhupathiraju S.N., Tucker K.L. Greater variety in fruit and vegetable intake is associated with lower inflammation in Puerto Rican adults. Am J Clin Nutr 2011, 93:37-46.
190. He K., Song Y., Daviglus M.L., et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004, 109:2705-2711.
191. Whelton S.P., He J., Whelton P.K., Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 2004, 93:1119-1123.
192. Konig A., Bouzan C., Cohen J.T., et al. A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med 2005, 29:335-346.
193. Hu F.B., Cho E., Rexrode K.M., Albert C.M., Manson J.E. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 2003, 107:1852-1857.
194. de Goede J., Geleijnse J.M., Boer J.M., Kromhout D., Verschuren W.M. Marine (n-3) fatty acids, fish consumption, and the 10-year risk of fatal and nonfatal coronary heart disease in a large population of Dutch adults with low fish intake. J Nutr 2010, 140:1023-1028.
195. Streppel M.T., Ocke M.C., Boshuizen H.C., Kok F.J., Kromhout D. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur Heart J 2008, 29:2024-2030.
196. Erkkila A.T., Lichtenstein A.H., Mozaffarian D., Herrington D.M. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 2004, 80:626-632.
197. Levitan E.B., Wolk A., Mittleman M.A. Fatty fish, marine omega-3 fatty acids and incidence of heart failure. Eur J Clin Nutr 2010, 64:587-594.
198. Levitan E.B., Wolk A., Mittleman M.A. Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men. Eur Heart J 2009, 30:1495-1500.
199. Mozaffarian D., Bryson C.L., Lemaitre R.N., Burke G.L., Siscovick D.S. Fish intake and risk of incident heart failure. J Am Coll Cardiol 2005, 45:2015-2021.
200. Mozaffarian D., Lemaitre R.N., Kuller L.H., Burke G.L., Tracy R.P., Siscovick D.S. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003, 107:1372-1377.
201. Guallar E., Sanz-Gallardo M.I., van't Veer P., et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002, 347:1747-1754.
202. Virtanen J.K., Voutilainen S., Rissanen T.H., et al. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol 2005, 25:228-233.
203. Rissanen T., Voutilainen S., Nyyssonen K., Lakka T.A., Salonen J.T. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 2000, 102:2677-2679.
204. US Food and Drug Administration, 2004 EPA and FDA advice for women who might become pregnant, women who are pregnant, nursing mothers, young children. What you need to know about mercury in fish and shellfish 2004, US Department of Health and Human Services.
205. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
206. Office LSR, Whole grain intake and cardiovascular disease and whole grain intake and diabetes: A review. In: Moura FFD, editor. Bethesda, MD, 2008.
207. US Food and Drug Administration, Guidance for industry and staff: Whole grain label statement [Draft Guidance] 2006.
208. Trowell H. Ischemic heart disease and dietary fiber. Am J Clin Nutr 1972, 25:926-932.
209. Morris J.N., Marr J.W., Clayton D.G. Diet and heart: a postscript. Br Med J 1977, 2:1307-1314.
210. Mellen P.B., Walsh T.F., Herrington D.M. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis 2008, 18:283-290.
211. Anderson J.W. Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc 2003, 62:135-142.
212. He M., van Dam R.M., Rimm E., Hu F.B., Qi L. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation 2010, 121:2162-2168.
213. Nettleton J.A., Steffen L.M., Loehr L.R., Rosamond W.D., Folsom A.R. Incident heart failure is associated with lower whole-grain intake and greater high-fat dairy and egg intake in the Atherosclerosis Risk in Communities (ARIC) study. J Am Diet Assoc 2008, 108:1881-1887.
214. Lutsey P.L., Jacobs D.R., Kori S., et al. Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: the MESA Study. Br J Nutr 2007, 98:397-405.
215. US Food and Drug Administration, Health Claim Notification for Whole Grain Foods. In: US Department of Health and Human Services, editor, 1999.
216. De Moura F.F., Lewis K.D., Falk M.C. Applying the FDA definition of whole grains to the evidence for cardiovascular disease health claims. J Nutr 2009, 139:2220S-2226S.
217. McKeown N.M., Meigs J.B., Liu S., Wilson P.W., Jacques P.F. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 2002, 76:390-398.
218. Flint A.J., Hu F.B., Glynn R.J., et al. Whole grains and incident hypertension in men. Am J Clin Nutr 2009, 90:493-498.
219. Jensen M.K., Koh-Banerjee P., Franz M., Sampson L., Gronbaek M., Rimm E.B. Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1. Am J Clin Nutr 2006, 83:275-283.
220. Cleveland L.E., Moshfegh A.J., Albertson A.M., Goldman J.D. Dietary intake of whole grains. J Am Coll Nutr 2000, 19:331S-338S.
221. Hvidtfeldt U.A., Tolstrup J.S., Jakobsen M.U., et al. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation 2010, 121:1589-1597.
222. Roerecke M., Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol 2010, 171:633-644.
223. Bagnardi V., Zatonski W., Scotti L., La Vecchia C., Corrao G. Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health 2008, 62:615-619.
224. Mukamal K.J., Chen C.M., Rao S.R., Breslow R.A. Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. J Am Coll Cardiol 2010, 55:1328-1335.
225. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 2010, 55:1339-1347.
226. Koppes L.L., Dekker J.M., Hendriks H.F., Bouter L.M., Heine R.J. Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia 2006, 49:648-652.
227. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-1526.
228. Athyros V.G., Liberopoulos E.N., Mikhailidis D.P., et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology 2007, 58:689-697.
229. Ruidavets J.B., Ducimetiere P., Arveiler D., et al. Types of alcoholic beverages and blood lipids in a French population. J Epidemiol Community Health 2002, 56:24-28.
230. van de Wiel A., de Lange D.W. Cardiovascular risk is more related to drinking pattern than to the type of alcoholic drinks. Neth J Med 2008, 66:467-473.
231. Rimm E.B., Williams P., Fosher K., Criqui M., Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999, 319:1523-1528.
232. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M.B., Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001, 357:763-767.
233. Oliveira A., Rodriguez-Artalejo F., Lopes C. Alcohol intake and systemic markers of inflammation-shape of the association according to sex and body mass index. Alcohol Alcohol 2010, 45:119-125.
234. Djousse L., Lee I.M., Buring J.E., Gaziano J.M. Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms. Circulation 2009, 120:237-244.
235. Penumathsa S.V., Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol 2009, 87:275-286.
236. Hu F.B. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 2002, 13:3-9.
237. Sacks F.M., Obarzanek E., Windhauser M.M., et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol 1995, 5:108-118.
238. Fung T.T., Willett W.C., Stampfer M.J., Manson J.E., Hu F.B. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med 2001, 161:1857-1862.
239. Tucker K.L. Dietary patterns, approaches, and multicultural perspective. Appl Physiol Nutr Metab 2010, 35:211-218.
240. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease 1980, Harvard University Press, Cambridge, MA.
241. Dontas A.S., Zerefos N.S., Panagiotakos D.B., Vlachou C., Valis D.A. Mediterranean diet and prevention of coronary heart disease in the elderly. Clin Interv Aging 2007, 2:109-115.
242. Bach A., Serra-Majem L., Carrasco J.L., et al. The use of indexes evaluating the adherence to the Mediterranean diet in epidemiological studies: a review. Public Health Nutr 2006, 9:132-146.
243. Sofi F., Cesari F., Abbate R., Gensini G.F., Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008, 337:a1344.
244. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Skoumas I., Stefanadis C. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study. Vasc Med 2008, 13:113-121.
245. Panagiotakos D.B., Pitsavos C., Stefanadis C. Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis 2006, 16:559-568.
246. Panagiotakos D.B., Pitsavos C., Matalas A.L., Chrysohoou C., Stefanadis C. Geographical influences on the association between adherence to the Mediterranean diet and the prevalence of acute coronary syndromes, in Greece: the CARDIO2000 study. Int J Cardiol 2005, 100:135-142.
247. Chrysohoou C., Panagiotakos D.B., Aggelopoulos P., et al. The Mediterranean diet contributes to the preservation of left ventricular systolic function and to the long-term favorable prognosis of patients who have had an acute coronary event. Am J Clin Nutr 2010, 92:47-54.
248. Martinez-Gonzalez M.A., Garcia-Lopez M., Bes-Rastrollo M., et al. Mediterranean diet and the incidence of cardiovascular disease: a Spanish cohort. Nutr Metab Cardiovasc Dis 2010.
249. Buckland G., Gonzalez C.A., Agudo A., et al. Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study. Am J Epidemiol 2009, 170:1518-1529.
250. Fung T.T., Rexrode K.M., Mantzoros C.S., Manson J.E., Willett W.C., Hu F.B. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009, 119:1093-1100.
251. Carter S.J., Roberts M.B., Salter J., Eaton C.B. Relationship between Mediterranean Diet Score and atherothrombotic risk: findings from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atherosclerosis 2010, 210:630-636.
252. Rumawas M.E., Dwyer J.T., McKeown N.M., Meigs J.B., Rogers G., Jacques P.F. The development of the Mediterranean-style dietary pattern score and its application to the American diet in the Framingham Offspring Cohort. J Nutr 2009, 139:1150-1156.
253. De Lorgeril M., Salen P., Martin J.L., et al. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol 1996, 28:1103-1108.
254. de Lorgeril M., Salen P., Martin J.L., Monjaud I., Delaye J., Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999, 99:779-785.
255. McKeown P.P., Logan K., McKinley M.C., Young I.S., Woodside J.V. Session 4: CVD, diabetes and cancer: evidence for the use of the Mediterranean diet in patients with CHD. Proc Nutr Soc 2010, 69:45-60.
256. Tuttle K.R., Shuler L.A., Packard D.P., et al. Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial). Am J Cardiol 2008, 101:1523-1530.
257. Estruch R., Martinez-Gonzalez M.A., Corella D., et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145:1-11.
258. Harsha D.W., Lin P.H., Obarzanek E., Karanja N.M., Moore T.J., Caballero B. Dietary Approaches to Stop Hypertension: a summary of study results. DASH Collaborative Research Group. J Am Diet Assoc 1999, 99:S35-S39.
259. Conlin P.R., Chow D., Miller E.R., et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens 2000, 13:949-955.
260. Fung T.T., Chiuve S.E., McCullough M.L., Rexrode K.M., Logroscino G., Hu F.B. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 2008, 168:713-720.
261. Levitan E.B., Wolk A., Mittleman M.A. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med 2009, 169:851-857.
262. Levitan E.B., Wolk A., Mittleman M.A. Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79years. Am J Cardiol 2009, 104:1416-1420.
263. Folsom A.R., Parker E.D., Harnack L.J. Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease. Am J Hypertens 2007, 20:225-232.
264. Parikh A., Lipsitz S.R., Natarajan S. Association between a DASH-like diet and mortality in adults with hypertension: findings from a population-based follow-up study. Am J Hypertens 2009, 22:409-416.
265. Obarzanek E., Sacks F.M., Vollmer W.M., et al. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001, 74:80-89.
266. Appel L.J., Miller E.R., Jee S.H., et al. Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation 2000, 102:852-857.
267. McCullough M.L., Feskanich D., Rimm E.B., et al. Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in men. Am J Clin Nutr 2000, 72:1223-1231.
268. McCullough M.L., Feskanich D., Stampfer M.J., et al. Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in women. Am J Clin Nutr 2000, 72:1214-1222.
269. Kant A.K., Schatzkin A., Graubard B.I., Schairer C. A prospective study of diet quality and mortality in women. JAMA 2000, 283:2109-2115.
270. Michels K.B., Wolk A. A prospective study of variety of healthy foods and mortality in women. Int J Epidemiol 2002, 31:847-854.
271. Kaluza J., Hakansson N., Brzozowska A., Wolk A. Diet quality and mortality: a population-based prospective study of men. Eur J Clin Nutr 2009, 63:451-457.
272. Patterson R.E., Haines P.S., Popkin B.M. Diet quality index: capturing a multidimensional behavior. J Am Diet Assoc 1994, 94:57-64.
273. Seymour J.D., Calle E.E., Flagg E.W., Coates R.J., Ford E.S., Thun M.J. Diet Quality Index as a predictor of short-term mortality in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Am J Epidemiol 2003, 157:980-988.
274. Osler M., Helms Andreasen A., Heitmann B., et al. Food intake patterns and risk of coronary heart disease: a prospective cohort study examining the use of traditional scoring techniques. Eur J Clin Nutr 2002, 56:568-574.
275. Osler M., Heitmann B.L., Gerdes L.U., Jorgensen L.M., Schroll M. Dietary patterns and mortality in Danish men and women: a prospective observational study. Br J Nutr 2001, 85:219-225.
276. Moeller S.M., Reedy J., Millen A.E., et al. Dietary patterns: challenges and opportunities in dietary patterns research an Experimental Biology workshop, April 1, 2006. J Am Diet Assoc 2007, 107:1233-1239.
277. Halton T.L., Willett W.C., Liu S., et al. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med 2006, 355:1991-2002.
278. Stampfer M.J., Hu F.B., Manson J.E., Rimm E.B., Willett W.C. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000, 343:16-22.
279. Lockheart M.S., Steffen L.M., Rebnord H.M., et al. Dietary patterns, food groups and myocardial infarction: a case-control study. Br J Nutr 2007, 98:380-387.
280. Oliveira A., Lopes C., Rodriguez-Artalejo F. Adherence to the Southern European Atlantic Diet and occurrence of nonfatal acute myocardial infarction. Am J Clin Nutr 2010, 92:211-217.
281. Fung T.T., McCullough M.L., Newby P.K., et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2005, 82:163-173.
282. Nettleton J.A., Schulze M.B., Jiang R., Jenny N.S., Burke G.L., Jacobs D.R. A priori-defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2008, 88:185-194.
283. Bhupathiraju S.N., Lichtenstein A.H., Dawson-Hughes B., Tucker K.L. Adherence index based on the AHA 2006 Diet and Lifestyle Recommendations is associated with select cardiovascular disease risk factors in older Puerto Ricans. J Nutr 2011, 141:460-469.
284. Farchi G., Mariotti S., Menotti A., Seccareccia F., Torsello S., Fidanza F. Diet and 20-y mortality in two rural population groups of middle-aged men in Italy. Am J Clin Nutr 1989, 50:1095-1103.
285. Brunner E.J., Mosdol A., Witte D.R., et al. Dietary patterns and 15-y risks of major coronary events, diabetes, and mortality. Am J Clin Nutr 2008, 87:1414-1421.
286. Esposito K., Giugliano D. Mediterranean dietary patterns and chronic diseases. Am J Clin Nutr 2008, 88:1179-1180. author reply 1180-1171.
287. Millen B.E., Quatromoni P.A., Nam B.H., O'Horo C.E., Polak J.F., D'Agostino R.B. Dietary patterns and the odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Prev Med 2002, 35:540-547.
288. Millen B.E., Quatromoni P.A., Nam B.H., et al. Dietary patterns, smoking, and subclinical heart disease in women: opportunities for primary prevention from the Framingham Nutrition Studies. J Am Diet Assoc 2004, 104:208-214.
289. Heidemann C., Schulze M.B., Franco O.H., van Dam R.M., Mantzoros C.S., Hu F.B. Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation 2008, 118:230-237.
290. Shimazu T., Kuriyama S., Hozawa A., et al. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int J Epidemiol 2007, 36:600-609.
291. Kim Y.O. Dietary patterns associated with hypertension among Korean males. Nutr Res Pract 2009, 3:162-166.
292. Martinez-Ortiz J.A., Fung T.T., Baylin A., Hu F.B., Campos H. Dietary patterns and risk of nonfatal acute myocardial infarction in Costa Rican adults. Eur J Clin Nutr 2006, 60:770-777.
293. Nettleton J.A., Polak J.F., Tracy R., Burke G.L., Jacobs D.R. Dietary patterns and incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 2009, 90:647-654.
294. Harriss L.R., English D.R., Powles J., et al. Dietary patterns and cardiovascular mortality in the Melbourne Collaborative Cohort Study. Am J Clin Nutr 2007, 86:221-229.
295. Panagiotakos D., Pitsavos C., Chrysohoou C., et al. Dietary patterns and 5-year incidence of cardiovascular disease: a multivariate analysis of the ATTICA study. Nutr Metab Cardiovasc Dis 2009, 19:253-263.
296. Newby P.K., Muller D., Tucker K.L. Associations of empirically derived eating patterns with plasma lipid biomarkers: a comparison of factor and cluster analysis methods. Am J Clin Nutr 2004, 80:759-767.
297. Centritto F., Iacoviello L., di Giuseppe R., et al. Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr Metab Cardiovasc Dis 2009, 19:697-706.
298. Hamer M., Mishra G.D. Dietary patterns and cardiovascular risk markers in the UK Low Income Diet and Nutrition Survey. Nutr Metab Cardiovasc Dis 2010, 20:491-497.
299. van Dam R.M., Grievink L., Ocke M.C., Feskens E.J. Patterns of food consumption and risk factors for cardiovascular disease in the general Dutch population. Am J Clin Nutr 2003, 77:1156-1163.
300. Huijbregts P.P., Feskens E.J., Kromhout D. Dietary patterns and cardiovascular risk factors in elderly men: the Zutphen Elderly Study. Int J Epidemiol 1995, 24:313-320.
301. Lopez E.P., Rice C., Weddle D.O., Rahill G.J. The relationship among cardiovascular risk factors, diet patterns, alcohol consumption, and ethnicity among women aged 50years and older. J Am Diet Assoc 2008, 108:248-256.
302. Kerver J.M., Yang E.J., Bianchi L., Song W.O. Dietary patterns associated with risk factors for cardiovascular disease in healthy US adults. Am J Clin Nutr 2003, 78:1103-1110.
303. Hoffmann K., Zyriax B.C., Boeing H., Windler E. A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease. Am J Clin Nutr 2004, 80:633-640.
304. McNaughton S.A., Mishra G.D., Brunner E.J. Food patterns associated with blood lipids are predictive of coronary heart disease: the Whitehall II study. Br J Nutr 2009, 102:619-624.
305. Nettleton J.A., Steffen L.M., Schulze M.B., et al. Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2007, 85:1615-1625.
306. Liese A.D., Nichols M., Hodo D., et al. Food intake patterns associated with carotid artery atherosclerosis in the Insulin Resistance Atherosclerosis Study. Br J Nutr 2010, 103:1471-1479.